Catalyst Pharmaceutical (CPRX) Names Richard P. Rieger as Vice President, Commercial Operations
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Join SI Premium – FREE
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced that Richard P. Rieger has been appointed as Vice President, Commercial Operations, effective immediately. Rieger brings extensive corporate development and management consulting experience to Catalyst from the pharmaceutical, biotechnology and high-tech industries.
In this newly created position, Rieger will provide strategic leadership as the Company pursues business development and commercialization opportunities around its portfolio of drugs utilizing Catalyst's proprietary GABA aminotransferase inhibition (GABA-AT) technology for addictions, epilepsy and other diseases of the central nervous system (CNS). Rieger will report to Patrick J. McEnany, Catalyst's President and CEO.
In this newly created position, Rieger will provide strategic leadership as the Company pursues business development and commercialization opportunities around its portfolio of drugs utilizing Catalyst's proprietary GABA aminotransferase inhibition (GABA-AT) technology for addictions, epilepsy and other diseases of the central nervous system (CNS). Rieger will report to Patrick J. McEnany, Catalyst's President and CEO.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Ingredion names Diego Reynoso as CFO, effective October 2026
- Balfour Beatty names Sarah Brand VP of Tampa buildings ops
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
